4-amino-5-phenylpentanoic acid | 60546-79-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-amino-5-phenylpentanoic acid
• 英文别名: 4-azaniumyl-5-phenylpentanoate
• CAS: 60546-79-4
• 化学式: C₁₁H₁₅NO₂
• mdl: MFCD09036428
• 分子量: 193.246
• InChiKey: URBAOHLJWLYLQE-UHFFFAOYSA-N

物化性质

• 沸点：
  375.6±35.0 °C(Predicted)
• 密度：
  1.133±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-amino-5-phenylpentanoic acid 、 螺谷胺 在 氯甲酸乙酯 、 三乙胺 作用下， 生成 4-[[(4R)-5-(8-azaspiro[4.5]decan-8-yl)-4-[(3,5-dichlorobenzoyl)amino]-5-oxopentanoyl]amino]-5-phenylpentanoic acid
  参考文献：
  名称：

  Structure−Antigastrin Activity Relationships of New Spiroglumide Amido Acid Derivatives

  摘要：

  A series of new spiroglumide amido acid derivatives was synthesized and evaluated for their ability to inhibit the binding of cholecystokinin (CCK) to guinea pig brain cortex (CCKB receptors) and peripheral rat pancreatic acini (CCKA receptors), as well as to inhibit in vitro the gastrin-induced Ca2+ increase in rabbit gastric parietal cells. Appropriate chemical manipulations of the structure of spiroglumide (CR 2194), i.e., (R)-4-(3,5-dichlorobenzamido)-5-(8-azaspiro[4,5]decan-8-yl)-5-oxopentanoic acid, led to potent and selective antagonists of CCKB/gastrin receptors. Structure-activity relationships are discussed. Some of these new derivatives, as, for example, compound 54 (CR 2622), i.e., (S)-4-[[(R)-4'-[(3,5-dichlorobenzoyl)amino]-5'-(8-azaspiro[4.5] decan-8-yl)-5'-oxo-pentanonyl]amino]-5-(1-naphthylamino)-5- oxopentanoic acid, exhibit activity 70-170 times greater than that of spiroglumide, depending upon the model used (IC50 = 2 x 10(-8) vs 140 x 10(-8) mol in binding inhibition of [H-3]-N-Me-N-Leu-CCK-8 in guinea pig brain cortex and IC50 = 0.7 x 10(-8) vs 122.3 x 10(-8) mol in inhibition of gastrin-induced Ca2+ mobilization in parietal cells of rabbit, respectively). Computer-assisted conformational analysis studies were carried out in order to compare the chemical structure of both the agonist (pentagastrin) and the antagonist (54).

  DOI：

  10.1021/jm950372w
• 作为产物：
  描述：

  methyl-4-(E)-4-nitro-5-phenylpent-4-enoat 在 sodium tetrahydroborate 、 palladium 10% on activated carbon 、 氢气 作用下， 以 1,3-二噁烷 、 甲醇 、 乙醇 为溶剂， 20.0~30.0 ℃ 、2.0 MPa 条件下， 反应 25.5h， 生成 5-苄基-2-吡咯烷酮 、 4-amino-5-phenylpentanoic acid
  参考文献：
  名称：

  12元环二肽的合成，抗分枝杆菌活性及其对分枝杆菌InhA和PknB的影响。

  摘要：

  近年来，据报道，几种小的天然环肽和环二肽具有抗分枝杆菌活性。在此基础上，开发了一个合成途径，用于一小部分具有一个酰胺和两个酯键（环三肽肽）的十二元环化合物。在该系列中，已证明在低微摩尔范围内，环状系统对于抑制耻垢分枝杆菌和结核分枝杆菌的生长是必需的。开链前体和类似物没有活性。这些化合物调节了分枝杆菌蛋白激酶B（PknB）的自磷酸化。PknB抑制剂在µM浓度下对分枝杆菌有活性，而诱导剂则没有活性。PknB调节分枝杆菌还原酶InhA（异烟肼的靶标）的活性。该系列抗牛分枝杆菌BCG InhA过表达菌株的活性与亲本菌株没有区别，表明它们不抑制InhA。所有物质均无细胞毒性（HeLa> 5 µg / ml），也没有显示任何明显的抗增殖作用（HUVEC> 5 µg / ml； K-562> 5 µg / ml）。在本研究范围内，尚未鉴定出这种新型小环二肽的分子靶标，但数据表明与PknB或其他激酶的相互作用可能部分导致了这种活性。

  DOI：

  10.1016/j.bmc.2018.04.045

文献信息

• [EN] PIPECOLIC LINKER AND ITS USE FOR CHEMISTRY ON SOLID SUPPORT<br/>[FR] LIEUR PIPÉCOLIQUE ET SON UTILISATION POUR UNE CHIMIE SUR SUPPORT SOLIDE
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2010023295A1

  公开（公告）日：2010-03-04

  The present invention relates to a pipecolic linker and its use as a solid-phase linker in organic synthesis. Said pipecolic solid-phase linker may be used for coupling functional groups chosen between primary amines, secondary amines, aromatic amines, alcohols, phenols and thiols. In particular, said pipecolic solid-phase linker may be used for peptide or pseudopeptide synthesis, such as the reverse N to C peptide synthesis or the retro-inverso peptide synthesis, or for the synthesis of small organic molecules.

  本发明涉及一种吡啶哌酸链连接剂及其在有机合成中作为固相连接剂的用途。所述吡啶哌酸固相连接剂可用于将功能基团偶联在一起，这些功能基团可选择为一级胺、二级胺、芳香胺、醇、酚和硫醇。特别地，所述吡啶哌酸固相连接剂可用于肽或伪肽合成，例如反向N到C肽合成或反向逆转肽合成，或用于小有机分子的合成。
• SURFACE-MODIFIED POLYMERIC SUBSTRATES GRAFTED WITH A PROPERTIES-IMPARTING COMPOUND USING CLIP CHEMISTRY
  申请人：Centre National de la Recherche Scientifique (CNRS)

  公开号：US20190247551A1

  公开（公告）日：2019-08-15

  The present invention relates to an efficient method for grafting a properties-imparting compound onto a polymeric substrate containing carbon-hydrogen (C—H) bonds using clip chemistry. The method of the invention includes coating the substrate with the properties-imparting compound and irradiating it with a reactive light source, and repeating this sequence at least once. The present invention further relates to surface-modified polymeric substrates grafted with a properties-imparting compound, in particular obtained with the method of the invention, medical devices comprising same, and non-medical of said surface-modified polymeric substrates.

  本发明涉及一种将赋予性质的化合物嫁接到含有碳氢（C—H）键的聚合物基底的高效方法，使用剪切化学。该发明的方法包括用赋予性质的化合物涂覆基底，并用反应性光源照射它，至少重复这个序列一次。本发明还涉及经过赋予性质的化合物嫁接的表面改性聚合物基底，特别是使用本发明方法获得的，包括同样的医疗设备，以及非医疗用途的表面改性聚合物基底。
• Age Inhibitors
  申请人：Potier Pierre

  公开号：US20080249030A1

  公开（公告）日：2008-10-09

  The invention relates to a compound having general formula I, wherein: X represents CH 2 , C═O, C═S or CHOH, X represents CH 2 , C═O, C═S or CHOH, R 1 represents an amino acid which is optionally substituted by one or more halogen atoms, preferably fluorine, or by one or more CF 3 groups and n=0.1 or 2, or X represents CH 2 , C═O, C═S, CHOH, R 1 represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, preferably fluorine, or by one or more CF 3 groups and n=0 or 1, or XR 1 represent PO 3 H or SO 3 H and n=0.1 or 2; R 2 represents H, XR 1 , an alkyl group at C 1 -C 6 , an aralkyl group at C 1 -C 6 or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH 2 , a carboxylic group COOH, one or more halogen atoms, preferably fluorine, or one or more CF 3 groups; or the pharmaceutically-acceptable addition salts, isomers, enantiomers and diastereoisomers of said compound, mixtures thereof, and pharmaceutical or cosmetic compositions comprising same and the use thereof as an AGE-inhibitor drug that traps reactive carbonyl compounds.

  该发明涉及一种具有一般式I的化合物，其中：X代表CH2、C═O、C═S或CHOH，X代表CH2、C═O、C═S或CHOH，R1代表一种氨基酸，该氨基酸可以选择性地被一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代，n=0.1或2，或者X代表CH2、C═O、C═S、CHOH，R1代表含有两个氨基酸的肽，每个氨基酸可以选择性地被一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代，n=0或1，或者XR1代表PO3H或SO3H，n=0.1或2；R2代表H、XR1、C1-C6的烷基、C1-C6的芳基烷基或芳基，其中烷基、芳基烷基和芳基可以被氨基NH2、羧基COOH、一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代；或者所述化合物的药学上可接受的加合盐、异构体、对映体和二对映异构体，其混合物，以及包含其的制药或化妆品组合物及其作为捕捉反应性羰基化合物的AGE抑制剂药物的用途。
• Diagnostic and therapeutic agents
  申请人：Taube Seija

  公开号：US20070258899A1

  公开（公告）日：2007-11-08

  Tumor targeting units are disclosed which have a peptide sequence C y —Y—G-F—X—W-G-Z-C yy (SEQ ID NO: 25), or a pharmaceutically or physiologically acceptable salt thereof. Tumor targeting agents are also disclosed having at least one targeting unit, directly or indirectly coupled to at least one effector unit. Diagnostic or pharmaceutical compositions having at least one targeting unit or at least one targeting agent, and targeting units or targeting agents for the preparation of a medicament for the treatment of cancer related diseases (including cancer), especially for the treatment of colon/colorectal cancer or its metastases are also disclosed.

  揭示了具有肽序列Cy—Y—G-F—X—W-G-Z-Cyy（序列ID编号：25）或其药学或生理上可接受的盐的肿瘤靶向单元。还披露了具有至少一个靶向单元的肿瘤靶向剂，直接或间接地偶联至至少一个效应单元。还披露了具有至少一个靶向单元或至少一个靶向剂的诊断或药物组合物，以及用于制备治疗癌症相关疾病（包括癌症）的药物的靶向单元或靶向剂，特别是用于治疗结肠/结直肠癌或其转移的靶向单元或靶向剂。
• [EN] DERIVATIVES OF GLYCO-CF2-SERINE AND GLYCO-CF2-THREONINE<br/>[FR] DÉRIVÉS DE GLYCO-CF2-SÉRINE ET DE GLYCO-CF2-THRÉONINE
  申请人：TFCHEM

  公开号：WO2012085221A1

  公开（公告）日：2012-06-28

  The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, as well as to their process of preparation, their use in the peptide synthesis, said peptide and the use of said peptide.

  本发明涉及式(I)的化合物：或其药学上可接受的盐，互变异构体，立体异构体或任意比例的立体异构体混合物，特别是对映体混合物的混合物，尤其是外消旋混合物，以及它们的制备方法，它们在肽合成中的应用，所述肽及所述肽的应用。